Status:
COMPLETED
Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum
Lead Sponsor:
Ina-Respond
Collaborating Sponsors:
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Aged ≥2 Years in Schistosomiasis Affected Areas
Eligibility:
All Genders
2+ years
Brief Summary
This is a longitudinal cohort study that will be coordinated with the 2019 schistosomiasis stool survey in Napu. The study will use the stool survey results as entry criteria to identify subjects to b...
Detailed Description
Indonesia's plan for elimination of schistosomiasis by 2025 requires a better understanding of the factors associated with infection, effective epidemiologic monitoring, and optimization of diagnostic...
Eligibility Criteria
Inclusion
- Reside in schistosomiasis affected areas for at least 8 weeks.
- Age ≥2 years.
- Provides a documented informed consent for participants' ≥18 years old or informed consent by parents/legally accepted representative (LAR) or assent for minor participants prior to the study procedures.
- Willing to comply with the study procedures.
- Agrees to the collection and storage of specimens.
Exclusion
- None.
Key Trial Info
Start Date :
September 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 2 2020
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT03870204
Start Date
September 4 2019
End Date
July 2 2020
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Donggala Research and Development (R&D) Center, Ministry of Health of Indonesia
Donggala, Central of Sulawesi, Indonesia, 94353